COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,046 Articles (22,627 medRxiv, 8,419 bioRxiv)

Most recent first Previous |  Page 385: Articles 3841-3850  | Next

SARS-CoV-2 infections among 12 000 pregnant women, 2020, Finland - cross-testing of neutralization assays
Virtanen, J., Korhonen, E. M., Salonen, S., Vapalahti, O., Sironen, T., Jaaskelainen, A. J.
10.1101/2023.06.07.23290927 — Posted: 2023-06-12
Trends in medication use after the onset of the COVID-19 pandemic in the Republic of Ireland: an interrupted time series study
Mattsson, M., Hong, J. A., Frazer, J. S., Frazer, G. R., Moriarty, F.
10.1101/2023.06.09.23291202 — Posted: 2023-06-12
Impact of COVID-19 Pandemic on Sleep Including HRV and Physical Activity as Mediators: A Causal ML Approach
Khatibi, E., Abbasian, M., Azimi, I., Labbaf, S., Feli, M., Borelli, J., Dutt, N., Rahmani, A.
10.1101/2023.06.08.23291008 — Posted: 2023-06-12
User adherence and perceptions of a Volunteer-Led Telemonitoring and Teleorientation Service for COVID-19 community management in Peru: The COVIDA project
Escobar-Agreda, S., Silva-Valencia, J., Soto-Becerra, P., Reategui-Rivera, C. M., De la Cruz-Torralva, K., Chahuara-Rojas, M., Hernandez-Iriarte, B., Espinoza-Herrera, D. H., Delgado, C. A., Matassini Eyzaguirre, S. M., Vargas-Herrera, J. R., Rojas-Mezarina, L.
10.1101/2023.06.08.23291037 — Posted: 2023-06-12
Sustainability Indexes as Possible Predictors of Excess Mortality across OECD Countries during the Covid-19 Pandemic
LIU, L.
10.1101/2023.06.09.23291035 — Posted: 2023-06-12
Characteristics and outcomes of patients with COVID-19 at high risk of disease progression receiving sotrovimab, oral antivirals or no treatment in Scotland
Drysdale, M., Tibble, H., Patel, V., Gibbons, D. C., Lloyd, E., Kerr, W., Macdonald, C., Birch, H., Sheikh, A.
10.1101/2023.06.09.23291195 — Posted: 2023-06-12
Risk of Coronavirus Disease 2019 (COVID-19) among Those Up-to-Date and Not Up-to-Date on COVID-19 Vaccination
Shrestha, N. K., Burke, P. C., Nowacki, A. S., Gordon, S. M.
10.1101/2023.06.09.23290893 — Posted: 2023-06-12
Poor immunogenicity upon SARS-CoV-2 mRNA vaccinations in autoimmune SLE patients is associated with pronounced EF-mediated responses and anti-BAFF/Belimumab treatment.
Faliti, C. E., Anam, F., Cheedarla, N., Woodruff, M., Usman, S., Runnstrom, M., Van, T., Kyu, S., Ahmed, H., Morrison-Porter, A., Quehl, H., Haddad, N. S., Chen, W., Cheedarla, S., Neish, A., Roback, J. D., Antia, R., Khosroshahi, A., Lee, F. E.-H., Sanz, I.
10.1101/2023.06.08.23291159 — Posted: 2023-06-12
Assessment of the relationship between Google Trend search data on clinical symptoms and cases reported during the first wave of the COVID-19 outbreak in India.
Mutheneni, S. R., Vavilala, H., Mopuri, R.
10.1101/2023.06.08.23291183 — Posted: 2023-06-12
Global seasonal activities of respiratory syncytial virus before the COVID-19 pandemic: a systematic review
Shan, S., Zhang, W., Gao, H., Huang, P.-Y., Du, Z., Bai, Y., Lau, Y.-C., Chen, D., Lau, E. H., Nealon, J., Wu, P.
10.1101/2023.06.12.23291266 — Posted: 2023-06-12

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).